The relentless pursuit of effective treatments for influenza necessitates access to high-quality pharmaceutical intermediates. Among these, 1H-1,2,4-Triazole-1-Carboxamidine Monohydrochloride (CAS: 19503-26-5) stands out as a crucial component in the synthesis of peramivir, a significant antiviral drug. As a prominent manufacturer and supplier in China, we are dedicated to ensuring that the pharmaceutical industry has a consistent and reliable source for this vital compound.

Our expertise lies in producing 1H-1,2,4-Triazole-1-Carboxamidine Monohydrochloride with exceptional purity, a critical factor for its application in synthesizing peramivir. Peramivir, a neuraminidase inhibitor, plays a vital role in mitigating the severity of influenza infections. The quality of the intermediate directly impacts the final drug product's efficacy and safety, making our stringent quality control measures indispensable.

For procurement specialists and R&D scientists, identifying dependable suppliers is key to maintaining project timelines and budget adherence. We offer competitive pricing and a transparent supply chain, making it easier for you to buy this essential intermediate. Our manufacturing facilities in China are equipped to handle both small-scale research needs and large-volume industrial requirements, ensuring scalability for your projects.

The chemical properties of 1H-1,2,4-Triazole-1-Carboxamidine Monohydrochloride – its white crystalline form and stability – contribute to its ease of use in complex synthetic pathways. Its primary application in peramivir synthesis positions it as a cornerstone for influenza treatment development. By choosing us as your supplier, you are investing in a partnership that prioritizes quality, reliability, and cost-effectiveness.

We are committed to advancing pharmaceutical solutions for global health challenges like influenza. We invite you to connect with us to procure 1H-1,2,4-Triazole-1-Carboxamidine Monohydrochloride (CAS: 19503-26-5). Reach out for a quote or to discuss bulk orders, and let us support your mission to develop life-saving antiviral therapies.